Delcath Systems, Inc. (Nasdaq: DCTH) 34.2% HIGHER; announced that the FDA granted Delcath’s request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma, also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually. Click here for the full report.

Marvel (NYSE: MVL) 25.9% HIGHER; Disney (NYSE: DIS) and Marvel announced today that it has acquired is a deal valued at $4 billion dollars, or $50 per Marvel share based on the closing price of Disney stock on Friday, August 28. Under the terms of the agreement and based